27/04/2020

COVID-10: communication to Partners, Customers and Suppliers

Health and safety, a top priority for Fidia

According to Fidia Farmaceutici S.p.A mission and policy, health and safety of people, and of course of our employees, are absolute priority.
This is why we decided to reduce potential risks, asking our colleagues, partners, visitors, ecc… to work remotely as much as possible, as well as to strictly follow all the rules our Government has recently published.

As a consequence, we are either postponing or organizing meetings to take place digitally, in order to guarantee usual working activities, until the risk of infection is minimized

This is not affecting our working activities, thus we guarantee full operations in, from and to the factories.
Also, all transports of goods, in Italy and to foreign countries are guaranteed and operations proceed at normal capacity/as planned.
In addition to this, at present we do not foresee any issue related to the supply of materials from our suppliers.

We are sure you all agree on the precautions we are taking in this emergency period, and we will share updates when new information or guidelines need to be communicated.

Best regards

Carlo Pizzocaro
CEO Fidia Farmaceutici S.p.A.

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.